Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/23 16:27 | 11/9/23 | EQRX | Health | Drug | Pharmaceutical Preparations | Nallicheri Melanie | MA | DO | CEO | M.d | 1,386 | 2.21 | 0 | 627 | 0 | M | |||||||||||||||
12/23/21 20:47 | 12/17/21 | EQRX | Health | Drug | Pharmaceutical Preparations | Casdin Eli | MA | DT | M.ad | 0 | 0.00 | 0 | 8,659 | 22 | 48,187 | I | |||||||||||||||
12/21/21 06:30 | 12/17/21 | EQRX | Health | Drug | Pharmaceutical Preparations | Abernethy Amy | MA | D | M.d | 0 | 0.00 | 0 | 200 | New | 200 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |